Navigation Links
Intellect Neurosciences, Inc. to Present Data on Alzheimer's Vaccine at 13th International Congress of Immunology Conference
Date:8/20/2007

Chimeric Peptide Vaccine Aims to Use Memory Imprint to Yield a Strong and

Highly Specific Immune Response

NEW YORK, Aug. 20 /PRNewswire-FirstCall/ -- Intellect Neurosciences, Inc. (OTC Bulletin Board: ILNS) a biopharmaceutical company focused on development of disease-modifying therapeutic agents for the treatment and prevention of Alzheimer's disease and related disorders, announced today that Dr. Rachel Eren, Vice President Research, will present new data regarding the Company's RECALL-VAX(TM) chimeric peptide vaccine technology at the 13th International Congress of Immunology on Thursday, August 23, 2007 in Rio de Janeiro, Brazil. Mice immunized with RECALL-VAX(TM) constructs mounted a robust and highly specific immune response against beta-amyloid. The data demonstrate for the first time that a "free-end specific" polyclonal response to beta-amyloid can be achieved, potentially overcoming an important safety concern for active immunization of Alzheimer's disease patients.

"We are pleased with our scientists' progress in establishing important proof of principle for this novel and proprietary vaccine technology, which is designed to make active immunization safe and practical for treating Alzheimer's patients," commented Dr. Daniel Chain, Intellect's Chairman and CEO. He added: "We believe that RECALL-VAX(TM) could potentially be used prophylactically to prevent or delay the onset of Alzheimer's disease in elderly people."

"There are multiple challenges in developing a means to safely immunize elderly individuals and avoid the failures encountered in previous clinical trials sponsored by major pharmaceutical companies," commented Professor Benjamin Chain at the Department of Immunology and Molecular Pathology, Windeyer Institute of Medical Sciences, University College London. Professor Chain added: "The major challenges are the need to: (i) mount a robust immune response when the immune system has become senescent as
'/>"/>

SOURCE Intellect Neurosciences, Inc.

Copyright©2007 PR Newswire.

0

GOOD

Page: 1 2 3

Related biology technology :

1. Inline intellectual property raises legal issues
2. Intellectual Property: Are you an infringer?
3. Starting a tech business? Step 1 is minding the intellectual property
4. Protect your intellectual property before its too late
5. Protecting your intellectual property in overseas markets
6. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
7. Wisconsin firms to present at Cleantech venture capital event
8. New Sonic Foundry search engine finds words, phrases in video presentations
9. Lone Wisconsin firm to present at InvestMidwest
10. Sonic Foundry creates search engine for 7,000 expert video presentations
11. InvestMidWest calls for business presentations

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)... ROCKVILLE, Md., Nov. 20 ...at it has priced an underwritten public offering o...to the public of $3.30 per share. The approximate...e underwriting discounts and commissions, will be ...f our VLP-based vaccines, internal research and de...
(Date:11/20/2009)..., SEATTLE, Nov. 20 Cell...nnounced today that the Ninth Circuit Court of App...d that CTI should be allowed to pursue all of its ...ck to the District Court for trial. CTI filed a c...d-party reimbursement consultant for CTI,s product...
(Date:11/20/2009)... METTLER TOLEDO recently announced th...nar, “The Role of Process Analytical Technol...” on December 1, 2009. , ... Role of Process Analytical Technology (PAT) in Gr...cember 1, Process Analytical Technology (PAT) case...
(Date:11/19/2009)...PENHAGEN, Nov. 19 Danish Prince Jo...ulosic ethanol plant in Kalundborg, Denmark, on We...orld,s first and largest 2nd generation ethanol de...enzymes are used in the plant,s innovative process...n of Danisco, was the first to market with commerc...
Breaking Biology Technology:Novavax Prices Public Offering of Common Stock 2Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2
...ion Coagulation Monitor Offers Both Built-in ...ontrols, INDIANAPOLIS, Oct. 29 Roche Diagnostics...uilt-in controls and optional, external,liquid con...agulation,ensure accurate PT/INR (clotting time) t...cation. The handheld, battery-powered CoaguChek X...
...CORONA, Calif., Oct. 29 /PRNewswire-FirstCall/,-- ...ticals, Inc. announced,today that under a supply a..., Inc., Watson has launched Tilia(TM) Fe (norethin...nd ferrous fumarate tablets), the generic,version ...R) Fe. Under the terms of the agreement, Warner C...
...Tapestry,Pharmaceuticals, Inc. (Nasdaq: TPPH ) an...on Monday, November 5, 2007 at 12:00 p.m. Eastern ...any,s third quarter 2007,financial results and pro...ess release regarding its second quarter financial...call. To participate in the conference call, plea...
Other Biology Technology:Roche Diagnostics Launches CoaguChek XS Plus System to Provide New PT/INR Point-of-Care Solution for Non-Waived Anticoagulation Services 2Roche Diagnostics Launches CoaguChek XS Plus System to Provide New PT/INR Point-of-Care Solution for Non-Waived Anticoagulation Services 3Roche Diagnostics Launches CoaguChek XS Plus System to Provide New PT/INR Point-of-Care Solution for Non-Waived Anticoagulation Services 4Warner Chilcott and Watson Pharmaceuticals Announce Launch of Tilia(TM) Fe 2Warner Chilcott and Watson Pharmaceuticals Announce Launch of Tilia(TM) Fe 3Warner Chilcott and Watson Pharmaceuticals Announce Launch of Tilia(TM) Fe 4Tapestry to Host Conference Call on November 5th to Discuss Third Quarter 2007 Financial Results 2
(Date:11/19/2009)... NIH Director,s T-R01 Award , Speedier Lab Testin... Jaffrey, associate professor of pharmacology at W...esearchers to win a prestigious NIH Director,s Tra... of Health. Dr. Jaffrey and his colleagues are dev...s that may some day speed up lab testing by instan...
(Date:11/19/2009)...e professor in the Fischell Department of Bioengin...oscience Research and Technology Review Day with a...one and other types of tissue for implantation. ,...resented in an eight minute pitch by faculty membe...Fair, held November 12 at the University of Maryla...
(Date:11/19/2009)... have shown how an experimental drug might restore...uries by preventing short circuits caused when tin..., The chemical compound also might be developed ... nerves usually are not severed in a common type o...s, the drug offers hope as a possible treatment, s...
Breaking Biology News(10 mins):Weill Cornell science briefs: November 2009 2Weill Cornell science briefs: November 2009 3Weill Cornell science briefs: November 2009 4Weill Cornell science briefs: November 2009 5Bioreactor for bone tissue engineering wins professor venture fair 2Bioreactor for bone tissue engineering wins professor venture fair 3Drug studied as possible treatment for spinal injuries 2Drug studied as possible treatment for spinal injuries 3Jefferson Radiology Acquires Two Medical Imaging Center Offices 6143 1Jefferson Radiology Acquires Two Medical Imaging Center Offices 6143 2Alliance Seating 26amp 3B Mobility Launches Its ATP Development Program 6140 1Alliance Seating 26amp 3B Mobility Launches Its ATP Development Program 6140 2Over 2 200 veterans died in 2008 due to lack of health insurance 61079 1Over 2 200 veterans died in 2008 due to lack of health insurance 61079 2
... experiments with mice have found evidence that th...s in the eye essential for healthy vision. , The f...tal for eyesight called the retinal pigment epithe...archers writing in a recent issue of Investigative...a vital role in our visual health by forming the o...
...sity of Bristol has found a potential new treatmen.... Their work is reported in Nature Medicine. , The...shown that one particular antibiotic ? fosfomycin ...ineffective in laboratory conditions. , Because i...as never been considered for the treatment of list...
...e kilometers worldwide--about the area of Denmark....support few nonaquatic vertebrate species, but the...n of species and subspecies that are endemic (foun...ies, which seem to be largely restricted to North ...n a harsh environment in which seed abundance is l...
Other Biology News:Bone marrow may restore cells lost in vision diseases 2Bone marrow may restore cells lost in vision diseases 3Species unique to tidal marshes face threats 2
LS Columns from Miltenyi Biotec
Corning Erlenmeyer Flask, Pc, 250 ml, Plug Seal Cap, Sterile from Sigma-Aldrich
...reedom EVO384R are fast multi-channel pipetting pl...three different sizes, with a multi-channel head a...cant time saving, with true parallel processing of...th the Freedom EVOware program. Each of these ro...
...reedom EVO384R are fast multi-channel pipetting pl...three different sizes, with a multi-channel head a...cant time saving, with true parallel processing of...th the Freedom EVOware program. Each of these ro...
Biology Products: